The ‘all in the mind’ myth of myalgic encephalomyelitis/chronic fatigue syndrome | Nursing in Practice | 27 June 2016
From Nursing in Practice | 27 June 2016 | Article […]
Search Results for: mir
TGI Friday! Our weekly round-up of recently published research abstracts | 24 June 2016
TGI Friday! Our weekly round-up of recently published research abstracts | 24 June 2016 Read More »
This week – how much do physios know about hyper mobility syndrome? & the value of online forums to people with chronic conditions.
IiME conference – another important day for sharing ideas on research | 20 June 2016
IiME conference – another important day for sharing ideas on research | 20 June 2016 Read More »
Dr Charles Shepherd reports on the 2016 Invest in ME
‘I’ve suffered with ME since I was eight – and the way I’m treated hasn’t changed in 30 years’ | The Independent | 12 May 2016
From The Independent (Voices), 12 May 2016. Words by Jason
GMC impose conditions on Dr Nigel Speight’s licence to practice | 23 April 2016
GMC impose conditions on Dr Nigel Speight’s licence to practice | 23 April 2016 Read More »
The ME Association’s paediatric medical adviser Dr Nigel Speight had
TGI-Plus1 Friday | Our weekly round-up of recently published research abstracts | 18 March 2016
From PLoS One, 11 March 2016. Open access. MicroRNAs hsa-miR-99b,
Could you run for us in the London 10,000 event on May 30? | 29 January 2016
Could you run for us in the London 10,000 event on May 30? | 29 January 2016 Read More »
We have places for this year’s London 10,000 run on May
Rituximab
Rituximab appeared to represent a potential treatment for at least a subgroup of ME/CFS. But phase III trial results from Norway determined this was not the case.
‘With his son terribly ill, a top scientist takes on chronic fatigue syndrome’ | Washington Post | 5 October 2015
Whitney Dafoe was an award-winning photographer before he got sick
TGI Friday! Our weekly round-up of recently published research abstracts | 25 September 2015
This week – rintatolimod (Ampligen), natural killer cell activity and an activity pacing RCT.